Concepedia

Vancomycin-intermediate Resistance

Vancomycin-Intermediate Resistance is a phenotypic resistance category within Gram-positive bacteria characterized by a moderate reduction in susceptibility to vancomycin, typically defined by minimum inhibitory concentrations of 4–8 μg/mL, distinguishing it from both fully susceptible strains and those exhibiting high-level vancomycin resistance.

575

Publications

36.3K

Citations

2.7K

Authors

838

Institutions

Publications per year

2017–2026

106

Variants

Visa

Parents

Publications

575

Pulsed-Field Gel Electrophoresis Typing of Oxacillin-Resistant<i>Staphylococcus aureus</i>Isolates from the United States: Establishing a National Database

Linda K. McDougal, Christine D. Steward, George Killgore et al. · Journal of Clinical Microbiology · 2003 · 1.4K citations · Full text

, , +16

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

Keiichi Hiramatsu, Nanae Aritaka, Hideaki Hanaki et al. · The Lancet · 1997 · 1.3K citations

, , +12

Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in <i>Staphylococcus aureus</i>

Longzhu Cui, Xiaoxue Ma, Katsuhiro Sato et al. · Journal of Clinical Microbiology · 2003 · 492 citations

, , +15

Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate <i>Staphylococcus aureus</i>

Longzhu Cui, Eiji Tominaga, Hui‐min Neoh et al. · Antimicrobial Agents and Chemotherapy · 2006 · 431 citations · Full text

, , +17

Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05

Gregory E. Steinkraus, Roger L. White, Lawrence V. Friedrich · Journal of Antimicrobial Chemotherapy · 2007 · 421 citations · Full text

, , +17

1–5 of 575

Authors

2.7K

  1. MJ
    Michael J. Rybak

    Wayne State University, United States

    32 publications · 2K citations

    25

    h-index

  2. KH
    Keiichi Hiramatsu

    Juntendo University, Japan

    25 publications · 4K citations

    22

    h-index

  3. LC
    Longzhu Cui

    Jichi Medical University, Japan

    19 publications · 2.7K citations

    18

    h-index

  4. FC
    Fred C. Tenover

    Centers for Disease Control and Prevention, United States

    12 publications · 3.8K citations

    12

    h-index

  5. BP
    Benjamin P. Howden

    The University of Melbourne, Australia

    12 publications · 1.8K citations

    12

    h-index

1–5 of 2.7K

Institutions

838

  1. Wayne State University

    Detroit, United States

    29 h-index

    119 publications

    7K citations

  2. Juntendo University

    Tokyo, Japan

    27 h-index

    125 publications

    21.2K citations

  3. Eugene Applebaum College of Pharmacy and Health Sciences

    Detroit, United States

    23 h-index

    94 publications

    5K citations

  4. Centers for Disease Control and Prevention

    Atlanta, United States

    18 h-index

    82 publications

    22.5K citations

  5. Detroit Receiving Hospital

    Detroit, United States

    15 h-index

    40 publications

    3.5K citations

  6. Monash University

    Melbourne, Australia

    12 h-index

    45 publications

    6.6K citations

  7. Emory University

    Atlanta, United States

    11 h-index

    31 publications

    2.3K citations

  8. Rockefeller University

    New York, United States

    11 h-index

    33 publications

    3.8K citations

1–8 of 838

Venues

  1. Antimicrobial Agents and Chemotherapy

    AAC · 127 publications · 10.2K citations

    62

    h-index

  2. Journal of Antimicrobial Chemotherapy

    JAC · 50 publications · 2.7K citations

    31

    h-index

  3. Journal of Clinical Microbiology

    JCM · 49 publications · 5.5K citations

    31

    h-index

  4. PLoS ONE

    22 publications · 1.1K citations

    19

    h-index

  5. Clinical Infectious Diseases

    CID · 16 publications · 2.1K citations

    16

    h-index

1–5